双胎输血综合征的管理:更新与当前挑战
2004年随机试验确立胎儿镜为双胎输血综合征(TTTS)治疗金标准后,手术技术与专家培训的进步使至少一胎存活率提高至89%、双胎存活率提高至65%。本综述更新当前原则、问题与争议,涉及Solomon技术、胎儿镜相关产科风险、胎儿生长受限、手术时机及I–IV期各期管理策略。
要点
- Solomon技术通过降低术后双胎贫血-红细胞增多序列征和TTTS复发风险改善新生儿结局。
- 胎儿镜激光凝固术伴有显著产科风险,包括未足月胎膜早破、早产甚至胎盘早剥。
- 胎儿生长受限见于30%至50%病例,尤其多普勒指标异常时可能不利影响双胎存活率。
核心结论
- 自2004年随机试验确立胎儿镜为TTTS治疗金标准以来,手术技术和专家培训的进步使至少一胎存活率提高至89%、双胎存活率提高至65%,但仍存在许多挑战。
研究设计与样本
- 本综述更新TTTS当前的管理原则、问题与争议。
主要发现
- Solomon技术通过降低术后双胎贫血-红细胞增多序列征和TTTS复发风险改善新生儿结局。
- 胎儿镜激光凝固术伴有显著产科风险,包括未足月胎膜早破、早产甚至胎盘早剥。
- 胎儿生长受限见于30%至50%病例,尤其多普勒指标异常时可能不利影响胎儿镜术后双胎存活率。
- 胎儿镜时的孕周是关键预后因素,孕周越早与存活率越低相关。
- 新兴证据支持对无症状I期TTTS患者行期待管理并密切超声监测。
关键数值与推荐
- 至少一胎存活率为89%,双胎存活率为65%。
- 胎儿生长受限见于30%至50%病例。
- III期和IV期TTTS不应延迟激光凝固。
- 极早孕周诊断的II期TTTS可能受益于期待管理至16至17周妊娠。
- 无症状I期TTTS有新兴证据支持期待管理并密切超声监测。
临床怎么用
- III期和IV期TTTS不应延迟激光凝固。
- 极早孕周诊断的II期TTTS可能受益于期待管理至16至17周妊娠。
- 无症状I期TTTS有新兴证据支持期待管理并密切超声监测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since a 2004 randomized trial established fetoscopy as the gold standard for the treatment for twin-to-twin transfusion syndrome (TTTS), advancements in surgical technique and expert training have considerably improved survival rates to 89% for at least one fetus and 65% for both fetuses. However, many challenges remain. This review provides an update on the current principles, issues, and debates. The Solomon technique has helped improve neonatal outcomes by reducing the risks of postoperative twin anemia-polycythemia sequence and TTTS recurrence. Nevertheless, fetoscopic laser photocoagulation is associated with significant obstetrical risks, including preterm premature rupture of membranes, preterm delivery, and even placental abruption. Additionally, fetal growth restriction, observed in 30% to 50% of cases, may adversely affect double survival rates following fetoscopy, particularly when abnormal Doppler indices are present. Gestational age (GA) at the time of fetoscopy is a critical prognostic factor, as earlier GA is associated with lower survival rates. This consideration raises questions about the optimal timing of the procedure after TTTS diagnosis. Emerging evidence supports expectant management with close ultrasound monitoring for asymptomatic patients with stage I TTTS. In stage III and IV TTTS, laser photocoagulation should not be delayed, whereas stage II TTTS diagnosed at very early GAs might benefit from expectant management until 16 to 17 weeks of gestation. Further advancements, such as flexible video fetoscopy and computer-assisted fetal laser surgery, represent the next frontier in addressing these challenges.
引用
- Bouchghoul H, Madar H, Mattuizzi A, et al. Management of twin-to-twin transfusion syndrome: update and current challenges. Am J Obstet Gynecol MFM. 2025. PMID: 40480497. doi:10.1016/j.ajogmf.2025.101714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。